Parexel
-
Parexel ropes in Peyton Howell as CEO effective May 15, 2024
Chief Operating & Growth Officer Peyton Howell to succeed Jamie Macdonald Parexel providing the full range of Phase I to…
Read More » -
Parexel in strategic alliance with Japanese Foundation for cancer research
Collaboration streamlines patient access to oncology clinical trials; further expand Parexel’s Site Alliance Network across Asia/Pacific Parexel, one of the…
Read More » -
Parexel, n-Lorem Foundation to support development of new investigational therapies for nano-rare patients
Parexel to provide clinical operations, real-world data solutions and expertise including medical and regulatory alongside innovative clinical research tools Parexel,…
Read More »